This is the authors' abstract. We don't add key points for this paper.
Incidents of hemolytic uremic syndrome (HUS) include a subset of patients that exhibit mutations in C factor H. These mutations cluster in the C-terminal domains of factor H where previous reports have identified polyanion and C3b-binding sites. In this study, we show that recombinant human factor H with deletions at the C-terminal end of the protein loses the ability to control the spontaneous activation of the alternative C pathway on host-like surfaces. For the pathology of HUS, the findings imply that mutations that disrupt the normal functions of the C-terminal domains prevent host polyanion recognition. The resulting uncontrolled activation of complement on susceptible host tissues appears to be the initiating event behind the acute renal failure of familial HUS patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Michael K. Pangburn (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: